Picture of Medtronic logo

MDT Medtronic News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareConservativeLarge CapNeutral

REG - FIL Limited Covidien plc Medtronic, Inc. - Form 8.3 - [Covidien Plc] <Origin Href="QuoteRef">COV.N</Origin> <Origin Href="QuoteRef">MDT.N</Origin>

RNS Number : 5257U
FIL Limited
16 October 2014

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2007 (AS AMENDED)

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)

FMR LLC and/or one or more of its direct or indirect subsidiaries

And

FIL Limited and/or one or more of its direct and indirect subsidiaries

Company dealt in

COVIDIEN PLC

Class of relevant security to which the dealings being disclosed relate(Note 2)

Ordinary shares

Date of dealing

15-October-14

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security
dealt in
(Note 3)

Long

Short

Number (%)

Number (%)

(1) Relevant securities

18,836,849 4.17


(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

18,836,849 4.17

b) Interests and short positions in relevant securities of the company, other than the
class dealt in
(Note 3)

Class of relevant security:

Long

Short

Number (%)

Number (%)

(91) Relevant securities

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

3. DEALINGS(Note 4)

(91) Purchases and sales

Purchase/sale

Number of securities

Price per unit

Sale

100,729

86.3016 USD/ Share

Sale

39,800

86. USD/ Share

Buy

37,100

83.58 USD/ Share

Sale

41,800

82.75 USD/ Share

Sale

80,000

84.3 USD/ Share

Sale

100,000

84.25 USD/ Share

Sale

54,300

83.548 USD/ Share

Sale

1,400

83.6679 USD/ Share

Sale

20,960

83.6638 USD/ Share

Sale

1,698

83.6838 USD/ Share

Sale

2,300

83.7004 USD/ Share

Sale

400

83.65 USD/ Share

Sale

1,300

83.5477 USD/ Share

Sale

8,200

83.539 USD/ Share

Sale

159,943

85.8046 USD/ Share

Sale

108,300

85.73 USD/ Share

Sale

37,100

83.58 USD/ Share

Sale

7,300

84. USD/ Share

Sale

126,034

88.6677 USD/ Share

Buy

26,300

88.9688 USD/ Share

Buy

3,100

83.8398 USD/ Share

Sale

31,100

88.4764 USD/ Share

Sale

3,700

88.4932 USD/ Share

Sale

10,700

88.5574 USD/ Share

Sale

6,059

88.3666 USD/ Share

Sale

7,041

88.7695 USD/ Share

Buy

35,500

85.8848 USD/ Share

Buy

41,800

82.75 USD/ Share

Buy

108,300

85.73 USD/ Share

Buy

9

92.63 USD/ Share

Buy

68

93.08 USD/ Share

Buy

4

92.29 USD/ Share

Buy

31

92.70 USD/ Share

Sale

6

92.46 USD/ Share

Sale

1

93.03 USD/ Share

Buy

49

92.48 USD/Share

Sale

5

92.61 USD/ Share

Sale

13

92.65 USD/ Share

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction (Note 6)

Number of securities (Note 7)

Price per unit (Note 5)





(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise

price

Type, e.g. American, European etc.

Expiry

date

Option money

paid/received per unit (Note 5)








(ii) Exercising

Product name, e.g. call option

Number of securities

Exercise price per unit (Note 5)



(d) Other dealings (including transactions in respect of new securities)(Note 4)

Nature of transaction (Note 8)

Details

Price per unit (if applicable)(Note 5)



4. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached?(Note 9)NO

Date of disclosure

16 October 2014

Contact name

Alex Hagel

Telephone number

+44 (0)1737 837092

If a connected EFM, name of offeree/offeror with which connected

N/A

If a connected EFM, state nature of connection (Note 10)

N/A


This information is provided by RNS
The company news service from the London Stock Exchange
END
ISEBXBDGXUBBGSL

Recent news on Medtronic

See all news